Real-world outcome of rTMS treatment for depression within the Japanese public health insurance system: Registry data from Kansai TMS network

• DOI: 10.1016/j.ajp.2024.104082
• Publication Date: 2024-05-19T09:15:54Z
• Authors: Shinichi Imazu; Shunichiro Ikeda; Yuuki Toi; Shoko Sano; Tetsufumi Kanazawa; Kazuhiro Shinosaki; Banri Tsukuda; Akira Kita; Kenji Kuroda; Shun Takahashi
• Keywords: Depression; Public health insurance

This study registered consecutive cases to elucidate the efficacy of rTMS treatment for depression within Japanese public health insurance system. Of 102 patients with who received over left dorsolateral prefrontal cortex, 44 (43.1%) reached remission and 14 (13.7%) did not reach but responded treatment. No serious adverse events occurred. Low baseline HAMD-17 score was associated after Favorable outcomes were shown in this cohort Our results provide insights into real-world clinical setting.